Marker Therapeutics Earnings, Revenue beat In Q3
Investing.com - Marker Therapeutics reported on Thursday third quarter {{erl-993180||earnings that beat analysts' forecasts and revenue that topped expectations. Marker Therapeutics...
Neutral
or
Marker Therapeutics News & Analysis
-
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.90%
Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Utilities, Financials and Industrials sectors propelled shares higher while losses in the Technology,...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.34%
Investing.com – U.S. equities were lower at the close on Friday, as losses in the Oil & Gas, Basic Materials and Technology sectors propelled shares lower. At the close in NYSE, the Dow...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.30%
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Consumer Goods, Healthcare and Industrials sectors propelled shares higher. At the close in NYSE, the Dow...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
